Category: General

HBR: How One CEO Prepared Her Organization for Her Retirement

“Last year I decided it was time to shake things up at our investment management company.  After 12 years as president and then CEO, I thought it was time to shift some of my responsibilities to my partners.” In my most recent HBR post, I discuss the difficult process of preparing Aureus for an eventual CEO transition. Read…

[VIEW FULL POST]

WSJ: The New Business Banker: A Private-Equity Firm

One of the reasons that “official” interest rates are staying low is that the shadow lending economy has so much available cash to finance deals that traditional banks won’t.  PE firms are big players in the game now too. Read the full article in The Wall Street Journal

[VIEW FULL POST]

WSJ: Business-Loan Drought Ends for Banks

This WSJ article highlights the acceleration in U.S. bank lending, which had curiously slowed the last couple of years despite solid economic fundamentals. Reasons for the deceleration included political uncertainty leading up to and after the Presidential election, as well as uncertainty regarding healthcare and tax reform. Now with some more clarity around these issues…

[VIEW FULL POST]

NYT: A Drug Costs $272,000 a Year. Not So Fast, Says New York State.

It’s time for courts to weigh in on the issue of drug pricing.  As an investor, we want drug companies to earn a strong return on their investment – but using the “value of a life” thesis to justify price is too arbitrary as that might be infinite. Read the full article in The New…

[VIEW FULL POST]

NYT: Profits Are Soaring. The Stock Market Has Barely Noticed.

This article points out what we’ve observed, that U.S. corporations are experiencing very strong earnings and revenue growth but the stock market, which worries and predicts the future, is skeptical that this won’t last.  The tug of war is likely to continue through 2018, but the bulls have the latest upper hand. Read the full…

[VIEW FULL POST]